Gemma M. Ryan
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Dendrimers and Hyperbranched Polymers 4
-
- Inhalation and Respiratory Drug Delivery 3
- Respiratory Support and Mechanisms 1
- Co-authors
- Lisa M. Kaminskas (8 shared papers)Christopher J. H. Porter (8 shared papers)David J. Owen (6 shared papers)Brian D. Kelly (4 shared papers)Victoria M. McLeod (5 shared papers)Michelle P. McIntosh (2 shared papers)John M. Haynes (2 shared papers)Mark Williamson (2 shared papers)
- Journals
- Journal of Controlled Release (4 papers)Molecular Pharmaceutics (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Journal of Pharmaceutical Sciences (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- AustraliaCanadaUnited States
In The Last Decade
Gemma M. Ryan
11 papers receiving 678 citations
Peers
Comparison fields: 5 of 75
- Pharmaceutical Science 139
- Biomaterials 160
- Polymers and Plastics 138
- Pulmonary and Respiratory Medicine 208
- Oncology 146
Countries citing papers authored by Gemma M. Ryan
This map shows the geographic impact of Gemma M. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma M. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma M. Ryan more than expected).
Fields of papers citing papers by Gemma M. Ryan
This network shows the impact of papers produced by Gemma M. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma M. Ryan. The network helps show where Gemma M. Ryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Gemma M. Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 165 | |
| 2 | 2014 | 122 | |
| 3 | 2013 | 104 | |
| 4 | 2013 | 79 | |
| 5 | 2014 | 51 | |
| 6 | 2018 | 40 | |
| 7 | 2017 | 33 | |
| 8 | 2015 | 27 | |
| 9 | 2017 | 26 | |
| 10 | 2015 | 26 | |
| 11 | 2022 | 11 |
About Gemma M. Ryan
Gemma M. Ryan is a scholar working on Polymers and Plastics, Pulmonary and Respiratory Medicine, Oncology, Immunology and Biomedical Engineering, having authored 11 papers that have together received 684 indexed citations. Recurring topics across this work include Dendrimers and Hyperbranched Polymers (4 papers), Immunotherapy and Immune Responses (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), RNA Interference and Gene Delivery (2 papers), Glioma Diagnosis and Treatment (2 papers), Nanoplatforms for cancer theranostics (2 papers), Click Chemistry and Applications (1 paper) and Respiratory Support and Mechanisms (1 paper). The work is most often cited by research in Pharmaceutical Science (139 citations), Biomaterials (160 citations), Polymers and Plastics (138 citations), Pulmonary and Respiratory Medicine (208 citations) and Oncology (146 citations). Gemma M. Ryan has collaborated with scholars based in Australia, Canada and United States. Frequent co-authors include Lisa M. Kaminskas, Christopher J. H. Porter, David J. Owen, Brian D. Kelly, Victoria M. McLeod, Michelle P. McIntosh, John M. Haynes, Mark Williamson, Neeranat Thienthong and Marcel B. Bally. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, Nanomedicine Nanotechnology Biology and Medicine, Journal of Pharmaceutical Sciences and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.